Immunogenicity
Based on immunogenicity studies and experience with other vaccines, the new meningococcal conjugate vaccine (Menactra) should be highly effective in preventing meningococcal disease in older children, adolescents and adults. The duration of protection with the new vaccine is unknown. Immunogenicity has been inconsistent in infants and toddlers